• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年急性早幼粒细胞白血病患者早期死亡的临床特征研究

Study on clinical features of early death in older patients with acute promyelocytic leukemia.

作者信息

Zhao Yanqiu, Yu Xinru, Yan Liru, Shi Deli, Li Jinqiao, Hou Wenyi, Zhang Qisheng, Zhu Yuxin, Zhang Yingmei

机构信息

Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, People's Republic of China.

Department of Developmental-Behavioral Pediatrics, The Sixth Affiliated Hospital of Harbin Medical University, Harbin, 150001, People's Republic of China.

出版信息

Ann Hematol. 2025 Jan;104(1):183-192. doi: 10.1007/s00277-024-06165-1. Epub 2024 Dec 27.

DOI:10.1007/s00277-024-06165-1
PMID:39725701
Abstract

This study aimed to analyze the baseline clinical characteristics, as well as the clinical features and risk factors of early death (ED) in older patients with acute promyelocytic leukemia (APL). A retrospective analysis was conducted on 198 consecutive older patients (age ≥ 50 years) with newly diagnosed APL who received arsenic trioxide alone as induction therapy, with 354 younger patients (age < 50 years) as controls. Ten easily obtainable clinical parameters were selected. Compared with the younger group, the older group had less fever, lower white blood cell (WBC) count, lower levels of albumin, and higher levels of creatinine upon admission. While the younger group had higher levels of aspartate aminotransferase and lower levels of fibrinogen (all P < 0.05). The ED rate was significantly higher in the older group (21.7% vs. 12.4%; P = 0.004). The causes of ED in the older group were bleeding, infection, embolism, differentiation syndrome, and others, in order of incidence. The cumulative incidence of ED due to infection (P = 0.0003) and embolism (P = 0.034) was significantly higher in the older group. For the older patients, independent risk factors for ED were WBC count > 5.9 × 10 /L, albumin < 35.85 g/L, creatinine > 72.9 µmol/L and fibrinogen < 1.137 g/L; independent risk factor for bleeding ED was WBC count > 6.2 × 10 /L; while independent risk factors for infection ED were albumin < 36.55 g/L and fibrinogen < 1.035 g/L. The baseline clinical characteristics, the clinical features and risk factors of ED in older APL patients were all quite different from those in younger patients, so research specifically targeting older patients with APL is very necessary.

摘要

本研究旨在分析老年急性早幼粒细胞白血病(APL)患者的基线临床特征,以及早期死亡(ED)的临床特征和危险因素。对198例连续的新诊断APL老年患者(年龄≥50岁)进行回顾性分析,这些患者接受三氧化二砷单药诱导治疗,并选取354例年轻患者(年龄<50岁)作为对照。选择了10个易于获得的临床参数。与年轻组相比,老年组入院时发热较少、白细胞(WBC)计数较低、白蛋白水平较低、肌酐水平较高。而年轻组天冬氨酸转氨酶水平较高、纤维蛋白原水平较低(均P<0.05)。老年组的ED发生率显著更高(21.7%对12.4%;P=0.004)。老年组ED的原因依次为出血、感染、栓塞、分化综合征等。老年组因感染(P=0.0003)和栓塞(P=0.034)导致的ED累积发生率显著更高。对于老年患者,ED的独立危险因素为WBC计数>5.9×10⁹/L、白蛋白<35.85g/L、肌酐>72.9µmol/L和纤维蛋白原<1.137g/L;出血性ED的独立危险因素为WBC计数>6.2×10⁹/L;而感染性ED的独立危险因素为白蛋白<36.55g/L和纤维蛋白原<1.035g/L。老年APL患者的基线临床特征、ED的临床特征和危险因素均与年轻患者有很大不同,因此针对老年APL患者的专门研究非常必要。

相似文献

1
Study on clinical features of early death in older patients with acute promyelocytic leukemia.老年急性早幼粒细胞白血病患者早期死亡的临床特征研究
Ann Hematol. 2025 Jan;104(1):183-192. doi: 10.1007/s00277-024-06165-1. Epub 2024 Dec 27.
2
Comparative analysis of causes and predictors of early death in elderly and young patients with acute promyelocytic leukemia treated with arsenic trioxide.三氧化二砷治疗老年和年轻急性早幼粒细胞白血病患者早期死亡原因及预测因素的对比分析。
J Cancer Res Clin Oncol. 2020 Feb;146(2):485-492. doi: 10.1007/s00432-019-03076-x. Epub 2019 Nov 4.
3
Analysis of risk factors for early death in patients with acute promyelocytic leukaemia treated with arsenic trioxide.三氧化二砷治疗急性早幼粒细胞白血病患者早期死亡的危险因素分析。
Ann Hematol. 2022 May;101(5):1039-1047. doi: 10.1007/s00277-022-04788-w. Epub 2022 Feb 16.
4
Factors affecting thrombohemorrhagic early death in patients with acute promyelocytic leukemia treated with arsenic trioxide alone.三氧化二砷单独治疗急性早幼粒细胞白血病患者血栓出血性早期死亡的影响因素。
Blood Cells Mol Dis. 2019 Nov;79:102351. doi: 10.1016/j.bcmd.2019.102351. Epub 2019 Aug 1.
5
Difference in causes and prognostic factors of early death between cohorts with de novo and relapsed acute promyelocytic leukemia.初发和复发急性早幼粒细胞白血病队列早期死亡原因及预后因素的差异。
Ann Hematol. 2018 Mar;97(3):409-416. doi: 10.1007/s00277-017-3216-2. Epub 2017 Dec 30.
6
Gene mutations in acute promyelocytic leukemia early death in patients treated with arsenic trioxide alone.单用三氧化二砷治疗的急性早幼粒细胞白血病患者早期死亡的基因突变。
Clin Transl Oncol. 2021 Oct;23(10):2171-2180. doi: 10.1007/s12094-021-02625-6. Epub 2021 May 3.
7
Effects of peripheral blood leukocyte count and tumor necrosis factor-alpha on early death in acute promyelocytic leukemia.外周血白细胞计数和肿瘤坏死因子-α对急性早幼粒细胞白血病早期死亡的影响。
BMC Cancer. 2023 Jan 7;23(1):27. doi: 10.1186/s12885-022-10499-2.
8
Causes and prognostic factors for early death in patients with acute promyelocytic leukemia treated with single-agent arsenic trioxide.单药三氧化二砷治疗急性早幼粒细胞白血病患者早期死亡的原因及预后因素
Ann Hematol. 2017 Dec;96(12):2005-2013. doi: 10.1007/s00277-017-3130-7. Epub 2017 Sep 22.
9
Early predictor for differentiation syndrome in newly diagnosed acute promyelocytic leukaemia patients treated with single-agent arsenic trioxide.初诊急性早幼粒细胞白血病患者接受单药三氧化二砷治疗分化综合征的早期预测指标。
Ann Hematol. 2024 Oct;103(10):3947-3954. doi: 10.1007/s00277-024-05776-y. Epub 2024 Apr 29.
10
Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.口服砷剂联合维甲酸与静脉用砷剂联合维甲酸治疗非高危急性早幼粒细胞白血病的非劣效性、随机、3 期临床试验。
Lancet Oncol. 2018 Jul;19(7):871-879. doi: 10.1016/S1470-2045(18)30295-X. Epub 2018 Jun 5.

本文引用的文献

1
Factors associated with thrombo-hemorrhagic deaths in patients with Acute Promyelocytic leukemia treated with Arsenic Trioxide and all-trans retinoic acid.砷剂和全反式维甲酸治疗急性早幼粒细胞白血病患者血栓-出血死亡的相关因素。
Leuk Res. 2023 Nov;134:107392. doi: 10.1016/j.leukres.2023.107392. Epub 2023 Sep 19.
2
Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021.急性早幼粒细胞白血病:1991 年至 2021 年基于人群的 ATRA 和口服 ATO 治疗的流行病学和结局研究。
BMC Cancer. 2023 Feb 10;23(1):141. doi: 10.1186/s12885-023-10612-z.
3
A risk score based on real-world data to predict early death in acute promyelocytic leukemia.
基于真实世界数据的风险评分预测急性早幼粒细胞白血病的早期死亡。
Haematologica. 2022 Jul 1;107(7):1528-1537. doi: 10.3324/haematol.2021.280093.
4
Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide study.新诊断 APL 患者早期院内死亡的特征和预测因素:一项为期 13 年的全人群研究。
Blood Adv. 2021 Jul 27;5(14):2829-2838. doi: 10.1182/bloodadvances.2021004789.
5
Development of a risk grading system to identify patients with acute promyelocytic leukemia at high risk of early death.开发一种风险分级系统,以识别急性早幼粒细胞白血病早期死亡风险高的患者。
Cancer Manag Res. 2018 Sep 17;10:3619-3627. doi: 10.2147/CMAR.S167686. eCollection 2018.
6
Characteristics features and factors influencing early death in Acute promyelocytic leukemia; Experience from United Arab Emirates (UAE).急性早幼粒细胞白血病早期死亡的特征及影响因素;来自阿拉伯联合酋长国(UAE)的经验。
Int J Hematol. 2017 Jul;106(1):90-98. doi: 10.1007/s12185-017-2211-7. Epub 2017 Mar 14.
7
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial.维甲酸和三氧化二砷与维甲酸和化疗治疗非高危急性早幼粒细胞白血病的疗效比较:意大利-德国 APL0406 随机试验的最终结果。
J Clin Oncol. 2017 Feb 20;35(6):605-612. doi: 10.1200/JCO.2016.67.1982. Epub 2016 Oct 31.
8
Acute promyelocytic leukaemia is characterized by stable incidence and improved survival that is restricted to patients managed in leukaemia referral centres: a pan-Canadian epidemiological study.急性早幼粒细胞白血病的特点是发病率稳定且生存率提高,但仅限于在白血病转诊中心接受治疗的患者:一项全加拿大的流行病学研究。
Br J Haematol. 2014 Sep;166(5):660-6. doi: 10.1111/bjh.12931. Epub 2014 Apr 30.
9
Clinical characteristics of acute promyelocytic leukemia manifesting as early death.表现为早期死亡的急性早幼粒细胞白血病的临床特征
Mol Clin Oncol. 2013 Sep;1(5):908-910. doi: 10.3892/mco.2013.155. Epub 2013 Jul 23.
10
Management and treatment results in patients with acute promyelocytic leukaemia (APL) not enrolled in clinical trials.未纳入临床试验的急性早幼粒细胞白血病(APL)患者的管理和治疗结果。
Eur J Cancer. 2014 Apr;50(6):1159-68. doi: 10.1016/j.ejca.2013.11.023. Epub 2014 Jan 15.